LXRX logo

LXRXLexicon Pharmaceuticals Inc

$1.92
$0.03
(1.59%)
Today
Closed $1.92
$0.01
(0.52%)
After Hours
Updated: 07:57 PM EDT
EarningsAug 5
Mkt Cap$852.86M
Vol2.99M
News
all
press releases
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
Key PointsLexicon Pharmaceuticals focuses on precision medicines for chronic conditions, bolstered by significant revenue growth from its core drug programs...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200-Day Moving Average - Here's What Happened
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (LXRX) to Release Earnings on Thursday
Lexicon Pharmaceuticals (NASDAQ:LXRX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-lexicon-pharmaceuticals-inc-stock...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 1-Year High - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - What's Next...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Should You Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Still a Buy...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 6.3% Higher - Still a Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 6.3% - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - What's Next?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Pass Above 200 Day Moving Average - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Time to Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Should You Buy...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.